Wenzel Spine, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$132Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
243clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Varilift $61K associated (2023-2025)
- Primalok $7,938 associated (2023-2025)
- Implant $2,274 associated (2023-2025)
- Promalok $1,609 associated (2023-2025)
- Vma $239 associated (2023-2025)
- Varilift-C $174 associated (2023-2025)
- Esp $137 associated (2023-2025)
- Varilift-Lx $105 associated (2023-2025)
- Varilift Lx $87.79 associated (2023-2025)
- Primalok Sp $58.03 associated (2023-2025)
- Profile Esp $42.27 associated (2023-2025)
- Profile $22.81 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| George West | Houston, TX | Neurological Surgery | $17,173.55 |
| Michael Kremer | Holland, MI | Neurological Surgery | $15,417.00 |
| Ahmer Ghori | Fort Wayne, IN | Orthopaedic Surgery of The Spine | $14,809.48 |
| Adam Lewis | Corpus Christi, TX | Neurological Surgery | $13,895.30 |
| Jeffrey Arle | Burlington, MA | Neurological Surgery | $7,633.18 |
| Andrew Fine | Sarasota, FL | Neurological Surgery | $5,643.31 |
| Reginald Davis | Fort Myers, FL | Neurological Surgery | $4,554.76 |
| Louis Saeger | Edina, MN | Pain Medicine (Anesthesiology) | $3,884.21 |
| Tyler Keena | Fort Wayne, IN | Anesthesiology | $3,250.00 |
| Scott Schlesinger | Little Rock, AR | $2,883.42 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.